Intravenous Sphingosylphosphorylcholine Protects Ischemic and Postischemic Myocardial Tissue in a Mouse Model of Myocardial Ischemia/Reperfusion Injury
2010

Sphingosylphosphorylcholine Protects Heart Tissue in Mice

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): Christine Herzog, Martina Schmitz, Bodo Levkau, Ilka Herrgott, Jan Mersmann, Jan Larmann, Kai Johanning, Michael Winterhalter, Jerold Chun, Frank Ulrich Müller, Frank Echtermeyer, Reinhard Hildebrand, Gregor Theilmeier

Primary Institution: Hannover Medical School

Hypothesis

Does sphingosylphosphorylcholine (SPC) exert cardioprotective effects in a mouse model of myocardial ischemia with reperfusion?

Conclusion

SPC reduces infarct size and protects against myocardial reperfusion injury in mice.

Supporting Evidence

  • SPC reduced infarct size by 23%, 36%, and 50% in a dose-dependent manner.
  • SPC treatment decreased leukocyte recruitment to the infarcted area.
  • SPC protected cardiomyocytes from apoptosis in vitro.

Takeaway

This study shows that a substance called sphingosylphosphorylcholine can help protect the heart from damage when blood flow is restored after being blocked.

Methodology

Mice underwent myocardial ischemia for 30 minutes followed by 24 hours of reperfusion, with SPC administered intravenously before and after ischemia.

Potential Biases

Potential bias due to nonrandomized study design and strain-specific effects.

Limitations

The study was conducted in a nonrandomized design and used specific mouse strains.

Participant Demographics

Mice were age and sex matched.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2010/425191

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication